The global demand for Antitussive Drugs Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Antitussive drugs are a class of heterogeneous medications generally used to suppress dry cough in patients suffering from respiratory disorders. Antitussive drugs can cure various symptoms caused by the common cold, flu, allergies, hay fever, or other breathing disorders like sinusitis, bronchitis, etc. These drugs reduce the urge to cough in patients by acting on the cough center in the brain. They are either opiates or opioids like pholcodine, codeine, and dextromethorphan. One of the most used over-the-counter antitussive drugs is Dextromethorphan, and it is relatively safe. They are taken orally and are available in the form of syrup, tablets, or vapor. These drugs are not suitable for long-term use since they risk abuse and may even cause addiction.
Market Dynamics
A high rate of atmospheric pollution and the growing prevalence of respiratory disorders among the global population is the central stimulant for the growth of the cough suppressants market. The contagious nature of individual coughs and cough being a significant unmet medical need will further propel market growth. The demand for antitussive drugs will see a steady increase since persistent cough can harm a person's quality of life. Rising awareness and easy availability of these drugs will benefit market growth. Continuing research to produce cheap, effective cough suppressants with minimal side effects will hinder this market's growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of antitussive drugs.
Market Segmentation
This section of the antitussive drugs market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Drug Class
- Centrally Acting Drugs (Opioids and Non-opioids)
- Peripherally Acting Drugs (Phenoxdiazine and Others)
- Others
By Route of Administration
By End-Users
- Hospitals
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Antitussive Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Antitussive Drugs Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antitussive drugs market include Toray Industries, Zoetus, Pfizer, Novartis AG, Merck & Co., Sanofi, Glenmark Pharmaceuticals, Alkem Laboratories, Zydus Cadila, AstraZeneca, Cipla, and Johnson & Johnson, among others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . ANTITUSSIVE DRUGS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Drug Class
3.7.2 By Route of Administration
3.7.3 By End-Users
3.7.4 By Distribution Channel
3.7.5 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG CLASS
6.1 Overview by Drug Class
6.2 Historical and Forecast Data
6.3 Analysis by Drug Class
6.4 Centrally Acting Drugs (Opioids and Non-opioids) Market by Regions
6.5 Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Regions
6.6 Others Market by Regions
7 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 Overview by Route of Administration
7.2 Historical and Forecast Data
7.3 Analysis by Route of Administration
7.4 Oral Market by Regions
7.5 Inhalational Market by Regions
7.6 Others Market by Regions
8 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY END-USERS
8.1 Overview by End-Users
8.2 Historical and Forecast Data
8.3 Analysis by End-Users
8.4 Hospitals Market by Regions
8.5 Specialty Clinics Market by Regions
8.6 Others Market by Regions
9 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
9.1 Overview by Distribution Channel
9.2 Historical and Forecast Data
9.3 Analysis by Distribution Channel
9.4 Hospital Pharmacy Market by Regions
9.5 Retail Pharmacy Market by Regions
9.6 Others Market by Regions
10 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY
10.1. Regional Outlook
10.2. Introduction
10.3. North America
10.3.1. Overview, Historic and Forecast Data
10.3.2. North America By Segment
10.3.3. North America By Country
10.3.4. United State
10.3.5. Canada
10.3.6. Mexico
10.4. Europe
10.4.1. Overview, Historic and Forecast Data
10.4.2. Europe by Segment
10.4.3. Europe by Country
10.4.4. United Kingdom
10.4.5. France
10.4.6. Germany
10.4.7. Italy
10.4.8. Russia
10.4.9. Rest Of Europe
10.5. Asia Pacific
10.5.1. Overview, Historic and Forecast Data
10.5.2. Asia Pacific by Segment
10.5.3. Asia Pacific by Country
10.5.4. China
10.5.5. India
10.5.6. Japan
10.5.7. South Korea
10.5.8. Australia
10.5.9. Rest Of Asia Pacific
10.6. Latin America
10.6.1. Overview, Historic and Forecast Data
10.6.2. Latin America by Segment
10.6.3. Latin America by Country
10.6.4. Brazil
10.6.5. Argentina
10.6.6. Peru
10.6.7. Chile
10.6.8. Rest of Latin America
10.7. Middle East & Africa
10.7.1. Overview, Historic and Forecast Data
10.7.2. Middle East & Africa by Segment
10.7.3. Middle East & Africa by Country
10.7.4. Saudi Arabia
10.7.5. UAE
10.7.6. Israel
10.7.7. South Africa
10.7.8. Rest Of Middle East And Africa
11 . COMPETITIVE LANDSCAPE OF THE ANTITUSSIVE DRUGS COMPANIES
11.1. Antitussive Drugs Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments
12 . COMPANY PROFILES OF ANTITUSSIVE DRUGS INDUSTRY
12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Toray Industries
12.3.1. Company Overview
12.3.2. Financials
12.3.3. Products
12.3.4. Recent Developments
12.4. Zoetus
12.4.1. Company Overview
12.4.2. Financials
12.4.3. Products
12.4.4. Recent Developments
12.5. Pfizer
12.5.1. Company Overview
12.5.2. Financials
12.5.3. Products
12.5.4. Recent Developments
12.6. Novartis AG
12.6.1. Company Overview
12.6.2. Financials
12.6.3. Products
12.6.4. Recent Developments
12.7. Merck & Co.
12.7.1. Company Overview
12.7.2. Financials
12.7.3. Products
12.7.4. Recent Developments
12.8. Sanofi
12.8.1. Company Overview
12.8.2. Financials
12.8.3. Products
12.8.4. Recent Developments
12.9. Glenmark Pharmaceuticals
12.9.1. Company Overview
12.9.2. Financials
12.9.3. Products
12.9.4. Recent Developments
12.10. Alkem Laboratories
12.10.1. Company Overview
12.10.2. Financials
12.10.3. Products
12.10.4. Recent Developments
12.11. Zydus Cadila
12.11.1. Company Overview
12.11.2. Financials
12.11.3. Products
12.11.4. Recent Developments
12.12. AstraZeneca
12.12.1. Company Overview
12.12.2. Financials
12.12.3. Products
12.12.4. Recent Developments
12.13. Cipla
12.13.1. Company Overview
12.13.2. Financials
12.13.3. Products
12.13.4. Recent Developments
12.14. Johnson & Johnson
12.14.1. Company Overview
12.14.2. Financials
12.14.3. Products
12.14.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Drug Class (USD MN)
- Centrally Acting Drugs (Opioids and Non-opioids) Market by Geography (USD MN)
- Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis Market by Route of Administration (USD MN)
- Oral Market by Geography (USD MN)
- Inhalational Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by End-Users (USD MN)
- Hospitals Market by Geography (USD MN)
- Specialty Clinics Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Hospital Pharmacy Market by Geography (USD MN)
- Retail Pharmacy Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Antitussive Drugs Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Antitussive Drugs Report
- Market Research Process
- Market Research Methodology
- Global Antitussive Drugs Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Drug Class
- Market Attractiveness Analysis by Route of Administration
- Market Attractiveness Analysis by End-Users
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Drug Class (USD MN)
- Centrally Acting Drugs (Opioids and Non-opioids) Market by Geography (USD MN)
- Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by Route of Administration (USD MN)
- Oral Market by Geography (USD MN)
- Inhalational Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by End-Users (USD MN)
- Hospitals Market by Geography (USD MN)
- Specialty Clinics Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Hospital Pharmacy Market by Geography (USD MN)
- Retail Pharmacy Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.